T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Zoom
ZM
|
+$2.88B |
| 2 |
Eli Lilly
LLY
|
+$2.63B |
| 3 |
AstraZeneca
AZN
|
+$1.96B |
| 4 |
Fortinet
FTNT
|
+$1.66B |
| 5 |
Coupang
CPNG
|
+$1.63B |
Top Sells
| 1 |
NXP Semiconductors
NXPI
|
+$2.58B |
| 2 |
Morgan Stanley
MS
|
+$2.29B |
| 3 |
Airbnb
ABNB
|
+$2.07B |
| 4 |
NVIDIA
NVDA
|
+$1.8B |
| 5 |
Qualcomm
QCOM
|
+$1.79B |
Sector Composition
| 1 | Technology | 23.37% |
| 2 | Healthcare | 16.2% |
| 3 | Consumer Discretionary | 15.56% |
| 4 | Financials | 12.84% |
| 5 | Communication Services | 12.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Aramark
ARMK
$10.1B
| $9.12M | ﹤0.01% |
334,238
-37,380
| -10% | -$1.02M |
|
|
FTOC
1402
DELISTED
FTAC Olympus Acquisition Corp. Class A Ordinary Shares
FTOC
| $9.04M | ﹤0.01% |
+855,258
| New | +$9.04M |
|
1403
SolarEdge
SEDG
$1.72B
| $9M | ﹤0.01% |
31,308
+5,585
| +22% | +$1.61M |
|
1404
Markel Group
MKL
$24.7B
| $8.89M | ﹤0.01% |
7,802
-345
| -4% | -$393K |
|
|
OHPAU
1405
DELISTED
Orion Acquisition Corp. Unit
OHPAU
| $8.72M | ﹤0.01% |
+872,934
| New | +$8.72M |
|
1406
Arch Capital
ACGL
$34.4B
| $8.57M | ﹤0.01% |
223,428
-1,407
| -0.6% | -$54K |
|
1407
Wolfspeed
WOLF
$365M
| $8.54M | ﹤0.01% |
79,010
+11,553
| +17% | +$1.25M |
|
1408
HF Sinclair
DINO
$9.56B
| $8.53M | ﹤0.01% |
238,365
-16,449
| -6% | -$589K |
|
1409
Lyft
LYFT
$7.73B
| $8.49M | ﹤0.01% |
134,340
+30,175
| +29% | +$1.91M |
|
|
FRONU
1410
DELISTED
Frontier Acquisition Corp. Units
FRONU
| $8.47M | ﹤0.01% |
+853,365
| New | +$8.47M |
|
1411
Pliant Therapeutics
PLRX
$97.6M
| $8.42M | ﹤0.01% |
+214,157
| New | +$8.42M |
|
1412
Cheniere Energy
LNG
$51.9B
| $8.26M | ﹤0.01% |
114,686
+14,428
| +14% | +$1.04M |
|
|
EPZM
1413
DELISTED
Epizyme, Inc
EPZM
| $8.19M | ﹤0.01% |
940,231
-602,356
| -39% | -$5.25M |
|
|
BLSA
1414
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
| $8.18M | ﹤0.01% |
774,136
| – | – |
|
1415
MoonLake Immunotherapeutics
MLTX
$3.34B
| $8.11M | ﹤0.01% |
792,285
+4,500
| +0.6% | +$46.1K |
|
1416
Grand Canyon Education
LOPE
$5.89B
| $7.98M | ﹤0.01% |
74,517
+206
| +0.3% | +$22.1K |
|
|
EUCRU
1417
DELISTED
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
| $7.94M | ﹤0.01% |
786,890
+20,300
| +3% | +$205K |
|
|
VMW
1418
DELISTED
VMware, Inc
VMW
| $7.59M | ﹤0.01% |
50,429
+3,011
| +6% | +$453K |
|
1419
Arcturus Therapeutics
ARCT
$470M
| $7.56M | ﹤0.01% |
183,069
-1,239,110
| -87% | -$51.2M |
|
1420
Ranger Energy Services
RNGR
$298M
| $7.47M | ﹤0.01% |
1,363,569
| – | – |
|
1421
Berkshire Hathaway Class A
BRK.A
$1.06T
| $7.33M | ﹤0.01% |
19
| – | – |
|
1422
Arcosa
ACA
$4.67B
| $7.31M | ﹤0.01% |
112,367
+63,682
| +131% | +$4.15M |
|
1423
RB Global
RBA
$21.7B
| $7.27M | ﹤0.01% |
124,102
-5
| -0% | -$293 |
|
1424
Sensata Technologies
ST
$4.55B
| $7.04M | ﹤0.01% |
121,427
-28,090
| -19% | -$1.63M |
|
1425
Restaurant Brands International
QSR
$20.6B
| $7.01M | ﹤0.01% |
107,762
| – | – |
|